Anthracyclines induce DNA damage response-mediated protection against severe sepsis

Immunity

Volumn 39, Issue 5, 2013, Pages 874-884

  Figueiredo, Nuno ^a,b,c,d   Chora, Angelo ^a   Raquel, Helena ^a   Pejanovic, Nadja ^a   Pereira, Pedro ^a   Hartleben, Björn ^e   Neves Costa, Ana ^a   Moita, Catarina ^a   Pedroso, Dora ^a   Pinto, Andreia ^a   Marques, Sofia ^a   Faridi, Hafeez ^f   Costa, Paulo ^b   Gozzelino, Raffaella ^g   Zhao, Jimmy L ^h   Soares, Miguel P ^g   Gama Carvalho, Margarida ⁱ   Martinez, Jennifer ^j   Zhang, Qingshuo ^k   Döring, Gerd ^l   Grompe, Markus ^k   Simas, J Pedro ^a   Huber, Tobias B ^e   Baltimore, David ^h   Gupta, Vineet ^f   Green, Douglas R ^j   Ferreira, João A ^a   Moita, Luis F ^a,m   more..

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b EPE   (Portugal)

^c Gulbenkian Programme for Advanced Medical Education   (Portugal)

^d CHAMPALIMAUD FOUNDATION   (Portugal)

^e UNIVERSITY OF FREIBURG   (Germany)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^h CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

ⁱ UNIVERSITY OF LISBON   (Portugal)

^j ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^k OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^l UNIVERSITY OF TÜBINGEN   (Germany)

^m Lisbon Academic Medical Centre   (Portugal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; AUTOPHAGY PROTEIN 7; CHECKPOINT KINASE RAD3; DOUBLE STRANDED DNA; EPIRUBICIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; MEROPENEM; PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTHRACYCLINE; ANTIINFECTIVE AGENT; ATG7 PROTEIN, MOUSE; ATM PROTEIN, MOUSE; AUTACOID; FANCD2 PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN; THIENAMYCIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; DRUG EFFICACY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; SIGNAL TRANSDUCTION; ADENOVIRUS INFECTION; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CECUM; DEFICIENCY; DNA REPAIR; DRUG EFFECTS; GENETICS; IMMUNOLOGY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG; METABOLISM; PATHOPHYSIOLOGY; PERITONITIS; PHYSIOLOGY; RESPIRATORY TRACT INFECTION; SHOCK, SEPTIC; WHOLE BODY RADIATION;

ADENOVIRIDAE INFECTIONS; ANIMALS; ANTHRACYCLINES; ANTI-BACTERIAL AGENTS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CECUM; DNA DAMAGE; DNA REPAIR; EPIRUBICIN; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; INFLAMMATION; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; LUNG; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; ORGAN SPECIFICITY; PERITONITIS; RESPIRATORY TRACT INFECTIONS; SEPSIS; SHOCK, SEPTIC; THIENAMYCINS; WHOLE-BODY IRRADIATION;

EID: 84887559345     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.08.039     Document Type: Article

References (53)

1. Alexander A., Cai S.L., Kim J., Nanez A., Sahin M., MacLean K.H., Inoki K., Guan K.L., Shen J., Person M.D., et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl. Acad. Sci. USA 2010, 107:4153-4158.
2. Alexander A., Kim J., Walker C.L. ATM engages the TSC2/mTORC1 signaling node to regulate autophagy. Autophagy 2010, 6:672-673.
3. Angus D.C., Wax R.S. Epidemiology of sepsis: an update. Crit. Care Med. 2001, 29(Suppl):S109-S116.
4. Annane D., Aegerter P., Jars-Guincestre M.C., Guidet B. Current epidemiology of septic shock: the CUB-Réa Network. Am. J. Respir. Crit. Care Med. 2003, 168:165-172. CUB-Réa Network.
5. Boldin M.P., Taganov K.D., Rao D.S., Yang L., Zhao J.L., Kalwani M., Garcia-Flores Y., Luong M., Devrekanli A., Xu J., et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J.Exp. Med. 2011, 208:1189-1201.
6. Bone R.C., Sibbald W.J., Sprung C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992, 101:1481-1483.
7. Bray K., Mathew R., Lau A., Kamphorst J.J., Fan J., Chen J., Chen H.Y., Ghavami A., Stein M., DiPaola R.S., et al. Autophagy suppresses RIP kinase-dependent necrosis enabling survival to mTOR inhibition. PLoS ONE 2012, 7:e41831.
8. Briot D., Macé-Aimé G., Subra F., Rosselli F. Aberrant activation of stress-response pathways leads to TNF-alpha oversecretion in Fanconi anemia. Blood 2008, 111:1913-1923.
9. Chien W.S., Chen Y.H., Chiang P.C., Hsiao H.W., Chuang S.M., Lue S.I., Hsu C. Suppression of autophagy in rat liver at late stage of polymicrobial sepsis. Shock 2011, 35:506-511.
10. Ciccia A., Elledge S.J. The DNA damage response: making it safe to play with knives. Mol. Cell 2010, 40:179-204.
11. Cosentino C., Grieco D., Costanzo V. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J. 2011, 30:546-555.
12. Dalhoff A., Shalit I. Immunomodulatory effects of quinolones. Lancet Infect. Dis. 2003, 3:359-371.
13. Degenhardt K., Mathew R., Beaudoin B., Bray K., Anderson D., Chen G., Mukherjee C., Shi Y., Gélinas C., Fan Y., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006, 10:51-64.
14. Duprez L., Takahashi N., Van Hauwermeiren F., Vandendriessche B., Goossens V., Vanden Berghe T., Declercq W., Libert C., Cauwels A., Vandenabeele P. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 2011, 35:908-918.
15. Garrison S.P., Thornton J.A., Häcker H., Webby R., Rehg J.E., Parganas E., Zambetti G.P., Tuomanen E.I. The p53-target gene puma drives neutrophil-mediated protection against lethal bacterial sepsis. PLoS Pathog. 2010, 6:e1001240.
16. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N.Engl. J. Med. 2003, 348:138-150.
17. Houghtaling S., Timmers C., Noll M., Finegold M.J., Jones S.N., Meyn M.S., Grompe M. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 2003, 17:2021-2035.
18. Hsiao H.W., Tsai K.L., Wang L.F., Chen Y.H., Chiang P.C., Chuang S.M., Hsu C. The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock 2012, 37:289-296.
19. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
20. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19:5720-5728.
21. Khan A.A., Slifer T.R., Araujo F.G., Suzuki Y., Remington J.S. Protection against lipopolysaccharide-induced death by fluoroquinolones. Antimicrob. Agents Chemother. 2000, 44:3169-3173.
22. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., Agholme L., Agnello M., Agostinis P., Aguirre-Ghiso J.A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
23. Komatsu M., Waguri S., Ueno T., Iwata J., Murata S., Tanida I., Ezaki J., Mizushima N., Ohsumi Y., Uchiyama Y., et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J.Cell Biol. 2005, 169:425-434.
24. Krysko D.V., Kaczmarek A., Krysko O., Heyndrickx L., Woznicki J., Bogaert P., Cauwels A., Takahashi N., Magez S., Bachert C., Vandenabeele P. TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation. Cell Death Differ. 2011, 18:1316-1325.
25. Larsen R., Gozzelino R., Jeney V., Tokaji L., Bozza F.A., Japiassú A.M., Bonaparte D., Cavalcante M.M., Chora A., Ferreira A., et al. A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med. 2010, 2:51ra71.
26. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., Cohen J., Opal S.M., Vincent J.L., Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 2003, 31:1250-1256. SCCM/ESICM/ACCP/ATS/SIS.
27. Li W., Zhu S., Li J., Assa A., Jundoria A., Xu J., Fan S., Eissa N.T., Tracey K.J., Sama A.E., Wang H. EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem. Pharmacol. 2011, 81:1152-1163.
28. Lu J.V., Walsh C.M. Programmed necrosis and autophagy in immune function. Immunol. Rev. 2012, 249:205-217.
29. Marques S., Alenquer M., Stevenson P.G., Simas J.P. A single CD8+ Tcell epitope sets the long-term latent load of a murid herpesvirus. PLoS Pathog. 2008, 4:e1000177.
30. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N.Engl. J. Med. 2003, 348:1546-1554.
31. Matsushita N., Endo Y., Sato K., Kurumizaka H., Yamashita T., Takata M., Yanagi S. Direct inhibition of TNF-α promoter activity by Fanconi anemia protein FANCD2. PLoS ONE 2011, 6:e23324.
32. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
33. Medzhitov R., Schneider D.S., Soares M.P. Disease tolerance as a defense strategy. Science 2012, 335:936-941.
34. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
35. Montecucco A., Biamonti G. Cellular response to etoposide treatment. Cancer Lett. 2007, 252:9-18.
36. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., Englert J.A., Rabinovitch M., Cernadas M., Kim H.P., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011, 12:222-230.
37. Råberg L., Sim D., Read A.F. Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 2007, 318:812-814.
38. Råberg L., Graham A.L., Read A.F. Decomposing health: tolerance and resistance to parasites in animals. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2009, 364:37-49.
39. Rittirsch D., Huber-Lang M.S., Flierl M.A., Ward P.A. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 2009, 4:31-36.
40. Russell J.A. Management of sepsis. N.Engl. J. Med. 2006, 355:1699-1713.
41. Sauter K.A., Wood L.J., Wong J., Iordanov M., Magun B.E. Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome. Cancer Biol. Ther. 2011, 11:1008-1016.
42. Schneider D.S., Ayres J.S. Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 2008, 8:889-895.
43. Seixas E., Gozzelino R., Chora A., Ferreira A., Silva G., Larsen R., Rebelo S., Penido C., Smith N.R., Coutinho A., Soares M.P. Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc. Natl. Acad. Sci. USA 2009, 106:15837-15842.
44. Shen H.M., Codogno P. Autophagy is a survival force via suppression of necrotic cell death. Exp. Cell Res. 2012, 318:1304-1308.
45. Siu W.Y., Lau A., Arooz T., Chow J.P., Ho H.T., Poon R.Y. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms. Mol. Cancer Ther. 2004, 3:621-632.
46. Suffredini A.F., Munford R.S. Novel therapies for septic shock over the past 4 decades. JAMA 2011, 306:194-199.
47. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
48. Ulloa L., Tracey K.J. The "cytokine profile": a code for sepsis. Trends Mol. Med. 2005, 11:56-63.
49. Valentin-Vega Y.A., Kastan M.B. A new role for ATM: regulating mitochondrial function and mitophagy. Autophagy 2012, 8:840-841.
50. Vanderwerf S.M., Svahn J., Olson S., Rathbun R.K., Harrington C., Yates J., Keeble W., Anderson D.C., Anur P., Pereira N.F., et al. TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells. Blood 2009, 114:5290-5298.
51. Weber S.E., Tian H., Pirofski L.A. CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice. J.Immunol. 2011, 186:432-442.
52. Westbrook A.M., Schiestl R.H. Atm-deficient mice exhibit increased sensitivity to dextran sulfate sodium-induced colitis characterized by elevated DNA damage and persistent immune activation. Cancer Res. 2010, 70:1875-1884.
53. Zhang X., Wan G., Berger F.G., He X., Lu X. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell 2011, 41:371-383.